Fibrinogen Changes and Thrombosis in Endometriosis
Author Information
Author(s): Fini Eleonora, Argento Flavia Rita, Borghi Serena, Giurranna Elvira, Nencini Francesca, Cirillo Michela, Fatini Cinzia, Taddei Niccolò, Coccia Maria Elisabetta, Fiorillo Claudia, Becatti Matteo
Primary Institution: Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Firenze, Italy
Hypothesis
The study investigates the structural and functional changes in fibrinogen and their potential role in thrombosis among endometriosis patients.
Conclusion
Endometriosis patients show significant oxidative stress and fibrinogen modifications that may contribute to their increased risk of thrombosis.
Supporting Evidence
- Endometriosis affects approximately 176 million women worldwide.
- EM patients exhibited elevated reactive oxygen species (ROS) production compared to controls.
- Fibrinogen from EM patients showed significant structural alterations and impaired polymerization.
- Systemic oxidative stress was confirmed by decreased total antioxidant capacity in EM patients.
- Fibrinogen oxidation was associated with increased resistance to plasmin-induced lysis.
Takeaway
Women with endometriosis have changes in a protein called fibrinogen that can make their blood more likely to clot, which can be dangerous.
Methodology
This case-control study involved 71 endometriosis patients and 71 matched controls, measuring oxidative stress markers and analyzing fibrinogen structure and function.
Limitations
The study did not directly link fibrinogen changes to thrombotic events and had a limited sample size.
Participant Demographics
71 women with stage III/IV endometriosis and 71 matched healthy controls.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website